adivo Agreement
![](https://www.fyonibio.com/wp-content/uploads/2021/07/Cover-FyoniBio-news-events.jpg)
FyoniBio and adivo GmbH sign Service Agreement
![](https://www.fyonibio.com/wp-content/uploads/2023/01/Posting-Kooperation_adivo_thumabnail.jpg)
We are pleased to announce the signing of a Service Agreement with adivo covering the generation of a production cell line for their canine therapeutic mAb candidate.
For the project, FyoniBio will use its versatile CHOnamite® cell line development platform, that integrates a high-performance Transposase technology and comprises various host
cell lines to select the most suitable cell line to produce adivo’s canine mAb format at the highest quality and yield.